Upgrade to SI Premium - Free Trial

Virgin Galactic Announces Fourth Quarter and Full Year 2021 Financial Results

February 22, 2022 4:05 PM

TUSTIN, Calif.--(BUSINESS WIRE)-- Virgin Galactic Holdings, Inc. (NYSE: SPCE) (“Virgin Galactic” or the "Company”) today announced its financial results for the fourth quarter and full year ended December 31, 2021 and provided a business update.

“We remain on track and on schedule to complete our enhancement program and launch commercial service later this year,” said Michael Colglazier, Chief Executive Officer of Virgin Galactic. “We achieved many important milestones in 2021 that laid an essential foundation towards becoming a scaled, commercial operation. In recent weeks, we opened sales to the general public and launched our new global consumer brand. Demand for our one-of-a-kind experience remains strong, and we are currently building our operations to accommodate our growing customer base.”

Fourth Quarter and Full Year 2021 Business Highlights:

Fourth Quarter 2021 Financial Highlights:

Recent Updates:

Financial Guidance:

The following forward-looking statements reflect our expectations for the first quarter of 2022 as of February 22, 2022, and are subject to substantial uncertainty. Our results are based on assumptions that we believe to be reasonable as of this date, but may be materially affected by many factors, as discussed below in “Forward-Looking Statements.”

Conference Call Information

Virgin Galactic will host a conference call to discuss the results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) today. To access the conference call, parties should dial +1 844 200 6205 or +1 646 904 5544 and enter the conference ID number 022958. The live audio webcast along with supplemental information will be accessible on the Company’s Investor Relations website at https://investors.virgingalactic.com/events-and-presentations/. A recording of the webcast will also be available following the conference call.

About Virgin Galactic Holdings

Virgin Galactic is an aerospace and space travel company, pioneering human spaceflight for private individuals and researchers with its advanced air and space vehicles. It is developing a spaceflight system designed to connect the world to the love, wonder and awe created by space travel and to offer customers a transformative experience. You can find more information at https://www.virgingalactic.com/.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of federal securities laws with respect to Virgin Galactic Holdings, Inc. (the "Company"), including statements regarding the Company’s spaceflight systems, markets and expected flight schedule. These forward-looking statements generally are identified by words such as “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the "SEC"), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at www.virgingalactic.com. These filings identify and address other important risks and uncertainties that could cause the Company’s actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

USE OF NON-GAAP FINANCIAL MEASURES (UNAUDITED)

This presentation references certain financial measures that are not prepared in accordance with generally accepted accounting principles in the United States (GAAP), including Adjusted EBITDA, non-GAAP selling, general, and administrative expense, non-GAAP research and development expense and free cash flow. The Company defines Adjusted EBITDA as earnings before interest expense, taxes, depreciation and amortization, stock-based compensation, and certain other items the Company believes are not indicative of its core operating performance. It defines non-GAAP selling, general, and administrative expenses as selling, general, and administrative expenses other than stock-based compensation and non-capitalized transaction costs, and non-GAAP research and development expenses as research and development expenses other than stock-based compensation. It defines free cash flow as net cash used by operating activities less capital expenditures. None of these non-GAAP financial measures is a substitute for or superior to measures prepared in accordance with GAAP and should not be considered as an alternative to any other measures derived in accordance with GAAP.

The Company believes that presenting these non-GAAP financial measures provides useful supplemental information to investors about the Company in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by its management in financial and operational-decision making. However, there are a number of limitations related to the use of non-GAAP measures and their nearest GAAP equivalents. For example, other companies may calculate non-GAAP measures differently, or may use other measures to calculate their financial performance, and therefore any non-GAAP measures the Company uses may not be directly comparable to similarly titled measures of other companies.

VIRGIN GALACTIC HOLDINGS, INC.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(In thousands except for per share data)

Three Months Ended

Years Ended

(Unaudited)

December 31, 2021

December 31, 2020

December 31, 2021

December 31, 2020

Revenue

$

141

$

$

3,292

$

238

Cost of revenue

2

272

173

Gross profit

139

3,020

65

Selling, general, and administrative expenses

39,902

32,854

173,178

116,592

Research and development expenses

41,518

41,481

149,377

158,757

Operating loss

(81,281

)

(74,335

)

(319,535

)

(275,284

)

Change in fair value of warrants

(30,080

)

(34,650

)

(371,852

)

Interest income, net

417

262

1,183

2,241

Other income (expense)

72

9

182

14

Loss before income taxes

(80,792

)

(104,144

)

(352,820

)

(644,881

)

Income tax (benefit) expense

5

(28

)

79

6

Net loss

(80,797

)

(104,116

)

(352,899

)

(644,887

)

Other comprehensive loss:

Foreign currency translation adjustment

118

(48

)

129

(54

)

Unrealized loss on marketable securities

(1,566

)

(2,003

)

Total comprehensive loss

$

(82,245

)

$

(104,164

)

$

(354,773

)

$

(644,941

)

Net loss per share:

Basic and diluted

$

(0.31

)

$

(0.44

)

$

(1.43

)

$

(2.94

)

Weighted-average shares outstanding:

Basic and diluted

257,887,722

236,722,884

247,618,557

219,107,905

VIRGIN GALACTIC HOLDINGS, INC.

Consolidated Balance Sheets

(In thousands, except share data)

December 31, 2021

December 31, 2020

Assets

Current assets

Cash and cash equivalents

$

524,481

$

665,924

Restricted cash

25,549

13,031

Marketable securities, short-term

79,418

Inventories

29,668

30,483

Prepaid expenses and other current assets

19,476

18,489

Total current assets

678,592

727,927

Marketable securities, long-term

301,463

Property, plant, and equipment, net

47,498

53,148

Other non-current assets

41,281

22,915

Total assets

$

1,068,834

$

803,990

Liabilities and Stockholders' Equity

Current liabilities

Accounts payable

9,237

5,998

Accrued liabilities

28,787

22,982

Customer deposits

90,863

83,211

Other current liabilities

2,636

2,830

Total current liabilities

131,523

115,021

Non-current liabilities

Warrant liability

135,440

Other long-term liabilities

43,047

26,451

Total liabilities

$

174,570

$

276,912

Stockholders' Equity

Preferred stock, $0.0001 par value; 10,000,000 authorized; none issued and outstanding

Common stock, $0.0001 par value; 700,000,000 shares authorized; 258,166,417 and 236,123,659 shares issued and outstanding as of December 31, 2021 and 2020, respectively

26

23

Additional paid-in capital

2,019,750

1,297,794

Accumulated deficit

(1,123,643

)

(770,744

)

Accumulated other comprehensive income

(1,869

)

5

Total stockholders' equity

894,264

527,078

Total liabilities and stockholders' equity

$

1,068,834

$

803,990

VIRGIN GALACTIC HOLDINGS, INC.

Condensed Consolidated Statements of Cash Flows

(In thousands)

Three Months Ended

Years Ended

(Unaudited)

December 31, 2021

December 31, 2020

December 31, 2021

December 31, 2020

Cash flows from operating activities

Net loss

$

(80,797

)

$

(104,116

)

$

(352,899

)

$

(644,887

)

Stock-based compensation

13,101

11,749

61,805

30,324

Depreciation and amortization

2,883

2,783

11,518

9,781

Change in fair value of warrant liability

30,080

34,650

371,852

Other operating activities, net

53

21

11

96

Change in assets and liabilities

Inventories

(363

)

176

815

1,371

Other current and non-current assets

(9,807

)

(8,569

)

(3,465

)

(2,417

)

Accounts payable and accrued liabilities

6,111

(1,729

)

7,935

(1,010

)

Customer deposits

5,504

21

7,652

(151

)

Other current and non-current liabilities

(1,811

)

(512

)

1,215

1,882

Net cash used in operating activities

(65,126

)

(70,096

)

(230,763

)

(233,159

)

Cash flows from investing activities

Capital expenditures

(2,183

)

(3,540

)

(4,635

)

(17,201

)

Purchases of marketable securities

(96,752

)

(382,884

)

Net cash used in investing activities

(98,935

)

(3,540

)

(387,519

)

(17,201

)

Cash flows from financing activities

Payments of finance lease obligations

(35

)

(34

)

(140

)

(123

)

Repayment of notes payable

(310

)

(310

)

(310

)

Proceeds from issuance of common stock pursuant to stock options exercised

1,124

2,582

19,980

2,582

Withholding taxes paid on behalf of employee on net settled stock-based awards

(7,622

)

(4,368

)

(23,401

)

(4,767

)

Proceeds from issuance of common stocks

500,000

460,200

Transaction costs

(19

)

(122

)

(6,772

)

(20,988

)

Net cash provided by (used in) by financing activities

(6,552

)

(2,252

)

489,357

436,594

Net increase (decrease) in cash and cash equivalents

(170,613

)

(75,888

)

(128,925

)

186,234

Cash, cash equivalents and restricted cash at beginning of period

720,643

754,843

678,955

492,721

Cash, cash equivalents and restricted cash at end of period

$

550,030

$

678,955

$

550,030

$

678,955

VIRGIN GALACTIC HOLDINGS, INC.

Condensed Consolidated Statements of Cash Flows

(In thousands)

Three Months Ended

Years Ended

(Unaudited)

December 31, 2021

December 31, 2020

December 31, 2021

December 31, 2020

Cash and cash equivalents

$

524,481

$

665,924

$

524,481

$

665,924

Restricted cash

25,549

13,031

25,549

13,031

Cash, cash equivalents and restricted cash

$

550,030

$

678,955

$

550,030

$

678,955

Use of Non-GAAP Financial Measures (Unaudited)

This press release references certain financial measures that are not prepared in accordance with generally accepted accounting principles in the United States (GAAP), including Adjusted EBITDA, non-GAAP selling, general, and administrative expense and non-GAAP research and development expense. The Company defines Adjusted EBITDA as earnings before interest expense, taxes, depreciation and amortization, stock-based compensation, and certain other items the Company believes are not indicative of its core operating performance. It defines non-GAAP selling, general, and administrative expenses as selling, general, and administrative expenses other than stock-based compensation and non-capitalized transaction costs, and non-GAAP research and development expenses as research and development expenses other than stock-based compensation. None of these non-GAAP financial measures is a substitute for or superior to measures of financial performance prepared in accordance with GAAP and should not be considered as an alternative to any other performance measures derived in accordance with GAAP.

The Company believes that presenting these non-GAAP financial measures provides useful supplemental information to investors about the Company in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by its management in financial and operational-decision making. However, there are a number of limitations related to the use of non-GAAP measures and their nearest GAAP equivalents. For example, other companies may calculate non-GAAP measures differently, or may use other measures to calculate their financial performance, and therefore any non-GAAP measures the Company uses may not be directly comparable to similarly titled measures of other companies.

A reconciliation of Adjusted EBITDA to net loss for the three months ended December 31, 2021 and 2020 and years ended December 31, 2021 and 2020, respectively, are set forth below (in thousands):

Three Months Ended

Years Ended

December 31, 2021

December 31, 2020

December 31, 2021

December 31, 2020

Net Loss

$

(80,797

)

$

(104,116

)

$

(352,899

)

$

(644,887

)

Income tax (benefit) expense

5

(28

)

79

6

Interest expense

6

10

25

36

Depreciation & amortization

2,883

2,783

11,518

9,781

EBITDA

(77,903

)

(101,351

)

(341,277

)

(635,064

)

Non-capitalized transaction costs*

697

Stock-based compensation

13,101

11,749

61,805

30,324

Change in fair value of warrants

30,080

34,650

371,852

Adjusted EBITDA

$

(64,802

)

$

(59,522

)

$

(244,822

)

$

(232,191

)

A reconciliation of selling, general, and administrative expenses to non-GAAP selling, general, and administrative expenses for the three months ended December 31, 2021 and 2020 and years ended December 31, 2021 and 2020, respectively, are set forth below (in thousands):

Three Months Ended

Years Ended

December 31, 2021

December 31, 2020

December 31, 2021

December 31, 2020

Selling, general, and administrative expenses

$

39,902

$

32,854

$

173,178

$

116,592

Stock-based compensation

9,177

9,800

46,181

21,272

Depreciation and amortization

1,590

1,579

6,364

5,388

Non-capitalized transaction costs*

697

Non-GAAP selling, general, administration expenses

$

29,135

$

21,475

$

120,633

$

89,235

A reconciliation of research and development expenses to non-GAAP research and development expenses for the three months ended December 31, 2021 and 2020 and years ended December 31, 2021 and 2020, respectively, are set forth below (in thousands):

Three Months Ended

Years Ended

December 31, 2021

December 31, 2020

December 31, 2021

December 31, 2020

Research and development expenses

$

41,518

$

41,481

$

149,377

$

158,757

Stock-based compensation

3,924

1,949

15,624

9,052

Depreciation and amortization

1,293

1,204

5,155

4,393

Non-GAAP Research and development expenses

$

36,301

$

38,328

$

128,598

$

145,312

_______________

*

Non-capitalized transaction costs include non-recurring expenses related to preparation and filing of an S-1 registration statement in the first quarter of 2020.

The following table reconciles forecasted net cash used in operating activities to forecasted free cash flow for the three months ended March 31, 2022 (in thousands):

Forecasted Range

Net cash used in operating activities

($ 74,000) - ($ 82,000)

Capital expenditures

($ 1,000) - ($ 3,000)

Free cash flow

($ 75,000) - ($ 85,000)

For media inquiries:

Aleanna Crane - Vice President Communications

[email protected]

575.800.4422

For investor inquiries:

[email protected]

Source: Virgin Galactic Holdings, Inc.

Categories

Business Wire Press Releases

Next Articles